Showing results (451-460 of 472) with videos related to

Sort By:
Pageof 48
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
An international study to revise the EORTC questionnaire for assessing quality of life in lung cancer patientsM Koller, M J Hjermstad, K A Tomaszewski, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|May 9, 2008
[Guideline for the Early Detection of Breast Cancer in Germany 2008. Recommendations from the short version]U-S Albert, H Altland, Vf Duda, et al.
Plos Genetics|January 8, 2024
SH2 domain protein E and ABL signaling regulate blood vessel sizeJennifer A Schumacher, Zoë A Wright, Diandra Rufin Florat, et al.
Nature Communications|May 16, 2022
Hyperphosphorylated tau self-assembles into amorphous aggregates eliciting TLR4-dependent responsesJonathan X Meng, Yu Zhang, Dominik Saman, et al.
JAMA Ophthalmology|February 10, 2022
Visual Acuity and Ophthalmic Outcomes 5 Years After Cataract Surgery Among Children Younger Than 13 YearsMichael X Repka, Trevano W Dean, Raymond T Kraker, et al.
Nature Communications|January 27, 2023
Gold nanoparticle-enhanced X-ray microtomography of the rodent reveals region-specific cerebrospinal fluid circulation in the brainShelei Pan, Peter H Yang, Dakota DeFreitas, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|December 15, 2015
Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trialA M Horgan, G Darling, R Wong, et al.
JAMA Ophthalmology|April 24, 2020
Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of PrematurityDavid K Wallace, Raymond T Kraker, Sharon F Freedman, et al.
JAMA Ophthalmology|April 28, 2017
Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing StudyDavid K Wallace, Raymond T Kraker, Sharon F Freedman, et al.
Pageof 48